These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8839934)

  • 21. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
    Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortisol and hypertension: what was not so apparent about "apparent mineralocorticoid excess".
    Edwards C; Walker B
    J Lab Clin Med; 1993 Dec; 122(6):632-5. PubMed ID: 8245680
    [No Abstract]   [Full Text] [Related]  

  • 23. 11 beta-Hydroxysteroid dehydrogenase: a link between the dysregulation of cortisol metabolism and hypertension.
    Donovan SJ
    Br J Biomed Sci; 1999; 56(3):215-25. PubMed ID: 10824333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 11 beta-Hydroxysteroid dehydrogenase.
    Stewart PM; Krozowski ZS
    Vitam Horm; 1999; 57():249-324. PubMed ID: 10232052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monogenic hypertension].
    Bähr V; Oelkers W; Diederich S
    Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inherited forms of mineralocorticoid hypertension.
    Hassan-Smith Z; Stewart PM
    Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):177-85. PubMed ID: 21494136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [11 beta-hydroxysteroid-dehydrogenase: characteristics and the clinical significance of a key enzyme in cortisol metabolism].
    Kerstens MN; Dullaart RP
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):509-14. PubMed ID: 10321259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population.
    Quinkler M; Bappal B; Draper N; Atterbury AJ; Lavery GG; Walker EA; DeSilva V; Taylor NF; Hala S; Rajendra N; Stewart PM
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):143-9. PubMed ID: 15134813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension.
    van Uum SH; Lenders JW; Hermus AR
    Semin Vasc Med; 2004 May; 4(2):121-8. PubMed ID: 15478032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditional Deletion of Hsd11b2 in the Brain Causes Salt Appetite and Hypertension.
    Evans LC; Ivy JR; Wyrwoll C; McNairn JA; Menzies RI; Christensen TH; Al-Dujaili EA; Kenyon CJ; Mullins JJ; Seckl JR; Holmes MC; Bailey MA
    Circulation; 2016 Apr; 133(14):1360-70. PubMed ID: 26951843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess.
    Ulick S; Tedde R; Mantero F
    J Clin Endocrinol Metab; 1990 Jan; 70(1):200-6. PubMed ID: 2403571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess.
    Ulick S; Tedde R; Wang JZ
    J Clin Endocrinol Metab; 1992 Mar; 74(3):593-9. PubMed ID: 1740492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apparent mineralocorticoid excess.
    Benediktsson R; Edwards CR
    J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralocorticoids, salt and high blood pressure.
    Gómez-Sánchez EP; Zhou M; Gomez-Sanchez CE
    Steroids; 1996 Apr; 61(4):184-8. PubMed ID: 8732997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-Specificity of Mineralocorticoid Target Gene Expression during Renal Development, and Long-Term Consequences.
    Dumeige L; Storey C; Decourtye L; Nehlich M; Lhadj C; Viengchareun S; Kappeler L; Lombès M; Martinerie L
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological, biochemical and molecular mechanisms of salt appetite control by mineralocorticoid action in brain.
    De Nicola AF; Grillo C; González S
    Braz J Med Biol Res; 1992; 25(12):1153-62. PubMed ID: 1341910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess.
    Tedde R; Pala A; Melis A; Ulick S
    J Endocrinol Invest; 1992 Jun; 15(6):471-4. PubMed ID: 1401749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the pleotropic actions of mineralocorticoids.
    Lang F
    Nephron Physiol; 2014; 128(1-2):1-7. PubMed ID: 25376771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syndromes of glucocorticoid and mineralocorticoid resistance.
    Zennaro MC
    Eur J Endocrinol; 1998 Aug; 139(2):127-38. PubMed ID: 9724063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.